




Sec. 3. In the implementation of the foregoing policy, the Government shall in accordance with the provisions of this Act:
b. Adopt measures to insure pure and safe supply of food, drug, and cosmetic in the country.
b. To provide for the collection of samples of food, drug and cosmetic.
c. To analyze and inspect food, drug and cosmetic in connection with the implementation of this Act.
d. To establish analytical data to serve as basis for the preparation of food, drug and cosmetic standards, and to recommend standards of identity, purity, quality and fill of container.
e. To issue certificate of compliance with technical requirements to serve as basis for the issuance of license and spot-check for compliance with regulations regarding operation of food, drug and cosmetic manufacturers and establishments.
f. To levy, assess and collect fees for inspection, analysis and testing of products and materials submitted in compliance with the provisions of this Act.
g. To certify batches of antibiotic and antibiotic preparations in compliance with the provisions of this Act.
b. Laboratory Division, which shall conduct all the tests analysis and trials of products covered by this Act.
Sec. 7. The Secretary of Health shall provide for the additional personnel needed to carry out the functions and duties of the Food and Drug Administration.
Sec. 8. The powers, functions and duties of the Division of Food and Drug Testing of the Bureau of Research and Laboratories and the Board of Food Inspection, all personnel in the Bureau of Health Services who are engaged in food and drug control work, together with all their equipment, supplies, records, files, personnel and balance of appropriations are transferred to the Food and Drug Administration. (Note: The Food and Drug Administration was abolished by Section 4 of Executive Order No. 851 dated December 2, 1982).
b. A representative of the Department of Agriculture and Natural Resources;
c. A representative of the Department of Commerce and Industry;
d. An authorized designate of the Commission of Customs;
e. An authorized representative of the Office of the Solicitor-General;
f. A technical member to be designated by the Food and Drug Administrator with the approval of the Secretary of Health;
g. The President of the Philippine Medical Association or his authorized representative;
h. The President of the Philippine Dental Association or his authorized representative;
i. The President of the Philippine Pharmaceutical Association or his authorized representative.
It
shall be the duty of the Board, conformably with the rules and
regulations,
to hold hearing and conduct investigations relative to matters touching
the administration of this Act, to investigate processes of food, drug
and cosmetic manufacture and to submit reports to the Food and Drug
Administrator,
recommending food and drug standards for adoption. Said Board shall
also
perform such additional functions, properly within the scope of the
administration
hereof, as may be assigned to it by the Food and Drug Administrator.
The
decisions of the board shall be advisory to the Food and Drug
Administrator.
b. "Secretary" means the Secretary of Health
c. "Department" means Department of Health
d. "Person" includes individual partnership corporation and association
e. "Food" means (1) articles used for food or drink for man, (2) chewing gum, and (3) articles used for components of any such article.
f. "Drug" means (1) articles recognized in the official United States Pharmacopoeia, official Momeopathic Pharmacopoeia of the United States, of official National Formulary or any supplement to any of them; and (2) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (3) articles (other than food) intended to affect the structure or any function of the body of man or animals; and (4) articles intended for use as component of any articles specified in clauses (1), (2), or (3), but does not include devices or their components, parts, or accessories.
g. "Device" means instrument, apparatus, or contrivances, including their components, parts, and accessories, intended (1) for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or animals; or (2) to affect the structure or any function of the body of man or animals.
h. "Cosmetics" means (1) articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and (2) articles intended for use as a component of any such articles.
i. "Label" means a display of written, printed, or graphic matter upon the immediate container of any article and a requirement made by or under authority of this Act that any word, statement, or other information appearing on the label shall not be considered to be complied with unless such word, statement, or wrapper, if any there be, of the retail package of such article, or easily legible through the outside container or wrapper.
j. "Immediate container" does not include package liners.
k. "Labelling" means all labels and other written, printer or graphic matter (1) upon any article or any of its containers or wrappers, or (2) accompanying such article.
l.
"New drugs" mean:
b. "Food additive" means any substance the intended use of which results or may reasonably be expected to result, directly or indirectly, in its becoming a component or otherwise affecting the characteristics of any food (including any substance intended for use in producing, manufacturing, packing, processing, preparing, treating, packaging, transporting, or holding food; and including any source of radiation intended for any such use), if such substance is not generally recognized, among experts qualified by scientific training and experience to evaluate its safety, as having been adequately shown through scientific procedures to be safe under the conditions of the intended use.
b. The adulteration or misbranding of any food, drug, device or cosmetic.
c. The refusal to permit entry or inspection as authorized by Section twenty-seven hereof or to follow samples to be collected.
d. The giving of a guaranty or undertaking referred to in Section twelve (a) hereof which guaranty or undertaking to the same effect signed by, and containing the name and address of, the person residing in the Philippines from whom he received in good faith the food, drug, device, or cosmetic or the giving of a guaranty or undertaking referred to in Section twelve (b) which guaranty or undertaking is false.
e. Forging, counterfeiting, simulating, or falsely representing or without proper authority using any mark, stamp, tag label, or other identification device authorized or required by regulations promulgated under the provisions of this Act.
f. The using by any person to his own advantage, or reveling, other than to the Secretary or officers or employees of the Department or to the courts when relevant in any judicial proceeding under this Act, any information acquired under authority of Section nine, or concerning any method or process which as a trade secret is entitled to protection.
g. The alteration, mutilation, destruction, obliteration, or removal of the whole or any part of the labeling of, or the doing of any other act with respect to, a food, drug, device, or cosmetic, if such act is done while such article is held for sale (whether or not the first sale) and results in such article being adulterated or misbranded.
h. The use, on the labeling of any drug or in any advertising relating to such drug, of any representation or suggestion that an application with respect to such drug is effective under Section twenty-one hereof, or that such drug complies with the provisions of such section.
i. The use, in labeling, advertising or other sales promotion of any reference to any report or analysis furnished in compliance with Section twenty-six hereof.
b. Any article of food, drug, device or cosmetic that is adulterated or misbranded when introduced into the domestic commerce may be seized and held in custody pending proceedings pursuant to section twenty-six (d) hereof, without hearing or court order, when the Secretary has probable cause to believe from facts found by him or any officer or employee of the Food and Drug Administration that the misbranded articles is fraudulent, or would be in a material respect misleading to the injury or damage of the purchaser or consumer.
2. If it consists in whole or in part of any filthy, putrid, or in part decomposed substance, or if it is otherwise unfit for food.
3. If it is, in whole or in part, the product of a diseased animal or of an animal which has died otherwise than by slaughter;
4.
If its container is composed, in whole or in part, of any poisonous or
deleterious substance which may render the contents injurious to health.
(4) if any substance has been added thereto or mixed or packed therewith so as to increase its bulk or weight, or reduce its quality or strength, or make it appear better or of greater value it is.
b. If it is a confectionary, and it bears or contains any alcohol or non-nutritive article or substance except harmless coloring, harmless flavoring, harmless resinous glass not in excess of four-tenths of one per centum, natural gum and pectin: Provided, That this paragraph shall not apply to any confectionary by reason of its containing less than one half of one per centum by volume of alcohol derived solely from the use of flavoring extracts, or to any chewing gum by reason of its containing harmless non-nutritive masticatory substances;
c. If it is oleomargarine or margarine or butter and any of the raw material used therein consists in whole or in part of any filthy, putrid or decomposed substance, or such oleomargarine, margarine or butter is otherwise unfit for food.
b. If it is offered for sale under the name of another food;
c. If it is an imitation of another food, unless its label bears in type of uniform size and prominence, the word "imitation" and immediately thereafter, the name of the food imitated;
d. It its container is so made, formed, or filled as to be misleading;
e. If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, numerical count: Provided, That under clause (2) of this paragraph reasonable variations shall be permitted, and exemptions as to small packages shall be established, by regulations prescribed by the Secretary.
f. If any word, statement, or other information required by or under authority of the act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other word, statements, designs, or devices, in the labeling), and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
g. It if purports to be or is represented as a food for which a definition and standard of identity has been prescribed unless (1) it conforms to such definition and standard, and (2) its label bears the name of the food specified in the definition and standard, and insofar as may be required by such regulations, the common names of optional ingredients (other than spices, flavoring, and coloring) present in such food.
h. If it purports to be or is represented as –
i. If it is not subject to the provisions of paragraph (g) of this section unless its label bears (1) the common or usual name of the food, if there be any, and (2) in case it is fabricated from two or more ingredients, the common or usual name of each such ingredient; except the spices, flavorings and colorings without naming each: Provided, That to the extent that compliance with the requirements of clause (2) of this paragraph is impracticable or results in deception or unfair competition, exemptions shall be established by regulations promulgated by the Secretary.
j. If it is purports to be or is presented for special dietary uses, unless its label bears such information concerning its vitamin, mineral and other dietary properties as the Secretary determines to be, and by regulations prescribes as necessary in order to fully inform purchasers as to its value for such uses.
k. If it bears or contains any artificial flavoring, artificial coloring, or chemical preservative, unless it bears labeling stating that fact: Provided, That to the extent that compliance with the requirements of this paragraph is impracticable, exemptions shall be established by regulations promulgated by the Secretary. The provisions of this paragraph or paragraphs (g) and (j) with respect to artificial coloring shall not apply in the case of butter, cheese or ice cream.
b. Any officer or employee duly designated by the Secretary shall have access to any factory or establishment, the operator of which holds a permit from the Secretary for the purpose of ascertaining whether or not the conditions of the permit are being complied with, and denial of access for such inspection shall be ground for suspension of the permit until such access is freely given by the operator.
(a)(1) If it consists in whole or in part of any filthy, putrid, decomposed substance; or (2) if it had been prepared, packed, or held under unsanitary conditions contaminated with filth or whereby it may have been rendered injurious to health; or (3) if it is a drug and its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health; or (4) if it is a drug and it bears or contains, for purposes of coloring only, a coal-tar color other than a permissible one.
b. If it is not subject to the provisions of paragraph (b) of this section and its strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.
c. If it is a drug and any substance has been (1) mixed or packed therewith so as to reduce its quality or strength or (2) substituted wholly or in part therefor.
b. If in a package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer or distributor; (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count: Provided, That reasonable variations shall be established by regulations prescribed by the Secretary.
c. If any work, statement, or other information required by or under authority of this Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
d. If it is for use by man and contains any quantity of the narcotic or hypnotic substance alpha-eucaine, barbituric acid, beta-eucaine, bromal, cannabis, cabromal, chloral, coca, cocaine, codeine, heroin, marijuana, morphine, opium, paraldehyde, peyote or sulfonmethane; or any chemical derivative of such substance, which derivative has been recommended by the Secretary, after investigation, and by regulations, designated as, habit forming; unless its label bears the name, and quantity or proportion of such substance or derivative and in juxtaposition therewith the statement "Warning – May be habit forming."
e. If it is a drug and is not designated solely by a name recognized in an official compendium unless its label bears (1) the common or usual name of the drug, if such there be; and (2) in case it is fabricated from two or more ingredients, the common or usual name of each active ingredient, including the quantity, kind, and proportion of any alcohol, and also including the quantity, kind, and proportion of any alcohol, and also including whether active or not, the name and quality of proportion of any bromides, either, chloroform, acetanilid, acetaphenetidin, amidopyrine, antipyrine, atropine, hyoscine, hyocyanamine, arsenic, digitalis, digitalis glycosides, mercyry, ouabain, strophantin, strychnine, thyroid, or any derivative or preparation of any such substances, contained therein: Provided, That where compliance with this paragraph is impracticable, exemptions shall, upon recommendation of the Food and Drug Administrator, be established by regulations promulgated by the Secretary.
f. Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users: Provided, That where any requirements of clause (1) of this paragraph, as applied to any drug or device, is not necessary for the protection of the public health, the Secretary shall, upon recommendation of the Food and Drug Administrator, promulgate regulations exempting such drug or device from such requirement.
g. If it purports to be a drug the name of which is recognized in an official compendium, unless it is packaged and labeled as prescribed therein: Provided, That the method of packing may be modified with the consent of the Secretary.
h. If it has been found by the Secretary to be a drug liable to deterioration, unless it is packaged in such form and manner, and its label bears a statement of such precautions, as the Secretary shall by regulations require as necessary for the protection of the public health.
i. (1) it if is a drug and its container is so made, formed, or filed as to be misleading; or
(2) if it is imitation of another drug; or
(3) if it is offered for sale under the name of another drug.
j. if it is dangerous to health when used in the dosage, or with the frequency of duration prescribed, recommended or suggested in the labeling thereof.
k. If it is, or purports to be, or is represented as a drug composed wholly or partly of any kind of penicillin, streptomycin, chlortetracycline, chloramphenicol, bacitracin, or any other antibiotic drug, or any derivative thereof, unless (1) it is from a batch with respect to which a certificate of release has been issued pursuant to Section twenty-two (a), and (2) such certificate of release is in effect with respect to such drug: Provided, That this paragraph shall not apply to any drug or class of drugs exempted by regulations promulgated under Section twenty-two (a), (b), and (c).
B. Because of its toxicity or other potentiality for harmful effect, or the method of its use is not safe for use except under the supervision of a practitioner licensed by law to administer such drug:
C. Are new drugs whose application are limited to investigational use shall be dispensed only (1) upon a written prescription of a practitioner licensed by law to administer such drug, or (2) an oral prescription of such practitioner which is reduced promptly to writing and filed by the pharmacist, or (3) by refilling any such written or oral prescription if such refilling is authorized by the prescriber either in the original prescription or by oral order which is reduced promptly to writing and filed by the pharmacist. The act of dispensing a drug contrary to the provisions of this paragraph shall be deemed to be an act which results in the drug being misbranded while held for sale.
2. The Secretary may be regulation remove drugs subject to Section nineteen (d) and Section twenty-one from the requirements of Subsection 9b) 91) of this Section, when such requirements are not necessary for the protection of the public health.
3. A drug which is subject to subsection (b) (1) of this section shall be deemed to be misbranded if at any time prior to dispensing, its label fails to bear the statement "Caution: Food, Drug and Cosmetics Law prohibits dispensing without prescription." A drug to which subsection (b) (1) of this Section does not apply shall be deemed to be misbranded if at any time prior to dispensing, its label bears the caution statement quoted in the preceding sentence.
(c) Within one hundred and eighty days after the filing of an application under this subsection, or such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall either – (1) approve the application if he then finds that none of the grounds for denying approval specified in subsection (d) applies, or (2) give the applicant notice of an opportunity for a hearing before the Secretary under subsection (d) on the question whether such application is approvable.
(d) If the Secretary finds, after due notice to the applicant and giving him an opportunity for a hearing, that (1) investigations, reports of which are required to be submitted to the Secretary pursuant to subsection (b), do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labelling thereof; (2) the results of such test show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions; (3) the methods used in, and the facilities and controls used for the manufacture, processing and packing of such drug are inadequate to preserve its identity, strength, quality, and purity; or (4) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug he has insufficient information to determine whether such drug is unsafe for use under such conditions; or (5) evaluated on the basis of the information submitted to him as part of the application, and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) based on a fair evaluation of all materials facts, such labeling is false or misleading in any particular; he shall issue an order refusing to approve the application.
(e) The effectiveness of an application with respect to any drug shall, after due notice and opportunity for hearing to the applicant, by order of the Secretary be suspended if the Secretary finds (1) that clinical experience, tests by new methods, or tests by methods not deemed reasonably applicable when such application became effective show that such drug is unsafe for use under the conditions of use upon the basis of which the application became effective, or (2) that the application contains any untrue statement of a material fact. The order shall state the findings upon which it is based.
(f) An order refusing to permit an application with respect to any drug to become effective shall be evoked whenever the Secretary finds that the facts so require.
(g)
The Secretary shall promulgated regulations for exempting from the
operation
of this section drugs intended solely for investigational use by
experts
qualified by scientific training and experience to investigate the
safety
and effectiveness of drugs.
b. The Secretary shall promulgate regulations exempting from any requirement of this Section and Section nineteen (k), (1) drugs which are to be stored, processed, labeled, or repacked at establishments other than those where manufactured, on condition that such drugs comply with all such requirements upon removal from such establishments; (2) drugs which conform to applicable standards of identity, strength, quality, and purity prescribed by these regulations and are intended for use in manufacturing other drugs; and (3) drugs which are intended for investigational use by experts qualified by scientific training and experience to investigate the safety and efficacy of drugs.
b. If it contains in whole or in part of any filthy, putrid, or decomposed substance.
c. If it has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with the filth, or whereby it may have been rendered injurious to health.
d. If its container is composed, in whole or in parts.
e. If it is not hair dye and it bears or contains a coal-tar color other than one which is permissible.
b. If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical counts: Provided, That reasonable variations shall be permitted and exemptions as to small package shall be established, by regulations prescribed by the Secretary.
c. If any word, statement, or other information required by or under authority of this Act, to appear on label or labeling is not prominently placed thereon with such conspicuousness (as compared with other word, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
d. If its container is so made, formed, or filled as to be misleading.
(b) The Commissioner of Customs, the Commissioner of Internal Bureau and the Secretary of Health shall jointly prescribe regulations for the efficient enforcement of the provisions of Section thirty, except as otherwise provided therein. Such regulations shall be promulgated upon the recommendation of the Food and Drug Administrator and shall take effect at such time, after due notice, as the Secretary of Health shall determine.
b. When it appears to the Food and Drug Administrator from the report of the Food and Drug Laboratory that any article of food or any drug, or cosmetic secured pursuant to Section twenty-eight of this Act is adulterated or misbranded, he shall cause notice thereof to be given to the person or persons concerned and such person or persons shall be given an opportunity to be heard before the Board of Food and Drug Inspection and to submit evidence impeaching the correctness of the finding or charge in question.
c. When a violation of any provisions of this Act comes to the knowledge of the Food and Drug Administrator of such character that a criminal prosecution ought to be instituted against the offender, he shall certify the facts to the Secretary of Justice through the Secretary of Health, together with the chemist’s report, the findings of the Board of Food and Drug Inspection, or other documentary evidence on which the charge is based.
d. Nothing in this Act shall be construed as requiring the Food and Drug Administrator to certify for prosecution pursuant to sub-paragraph (e) hereof, minor violation of this Act whenever he believes that public interest will be adequately served by a suitable written notice or warning.
Sec. 28. (a) If the officer or employee making any such inspection of a factory, warehouse or other establishment has obtained any sample in the course of the inspection, upon completion of the inspection and prior to leaving the premises, he shall give to the owner, operator, or agent in charge a receipt describing the samples obtained.
(b) Whenever in the course of any such inspection of a factory or other establishment where food is manufactured, processed, or packed, the officer or employee making the inspection obtains a sample of any such food, and an analysis is made of such sample for the purpose of ascertaining whether such food consists in whole or in part of any filthy, putrid, or decomposed substance, or is otherwise unfit for food, a copy of the results of such analysis shall be furnished promptly to the owner, operator, or agent in charge.
(d)
A food, drug device, or cosmetic intended for export shall not be
deemed
to be adulterated or misbranded under this Act if it (1) conforms with
the specifications of the foreign purchaser, (2) is not in conflict
with
laws of the country to which it is intended for export. But if such
article
is sold or offered for sale in domestic commerce, this subsection shall
not exempt it from any of the provisions of this Act.
Sec. 33. Section eleven hundred and nine to Section eleven hundred twenty-nine of the Administrative Code, and such other laws, executive orders, rules and regulations inconsistent with the provisions of this Act are repealed.
Sec. 34. This Act shall take effect upon its approval.
|
|
|
|




